Business
Interim Results
Interim Results.
About this update from Ilika Plc
[{"type":"text","content":"\n \nRNS Number : 6535X Ilika plc 15 January 2014 \n \n\n\nIlika plc \n('Ilika,' the 'Company,' or the 'Group')\n \nInterim Results for the six months ended 31 October 2013\n \nIlika (AIM: IKA), the advanced cleantech materials discovery company, announces its unaudited interim results for the six months ended 31 October 2013, a period of continued progress with technology development, new partnerships, contract renewals and increased business development activity in Europe.\n \nIlika accelerates the discovery of new and patentable materials using its unique high throughput technologies process for identified end uses in the energy, electronics, aerospace and biomedical sectors.\n \nOperational Highlights\n· Global OEM trials underway with two of Ilika's proprietary materials\n· Grant of patent for low cost fuel cell catalyst in Japan \n· Significant technical progress made in the development of proprietary solid state battery technology\n \nPost Period End Events\n· Notice of allowance for patent for fuel cell catalyst technology in Europe\n· \"World's first\" for fabrication of a solid state battery that can be manufactured as a stack\n \nFinancial Summary\n· Total revenue for the period (inc. grants) up 57% to over £0.6m (1H 2012; £0.4m)\n· Gross margin up to 39% (1H 2012: 24%) \n· R&D expenditure (mainly solid state battery technology) at comparable levels to 2012\n· Substantial non-operational cost savings achieved across the group\n· Operating loss reduced by 20% to £1.5m (1H 2012: £1.9m loss)\n· Net Cash £1.4m (1H 2012: £3.6m)\n \nCommenting on the results Ilika's Chairman, Jack Boyer, said: \"The first six months of our current financial year have yielded significant progress. Firstly, global OEMs are actively evaluating two of Ilika's proprietary materials, most notably the fuel cell catalyst material, indicating that Ilika has made strong progress in licensing out its IP portfolio. This commercialisation activity has been underpinned by the further grant of patents in Ilika's key target markets. Secondly, the invest...